Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,089 INR | +1.41% |
|
-0.17% | +57.96% |
06-14 | Zydus Lifesciences Gets US FDA's Tentative Approval for Generic Hypertension Drug | MT |
05-30 | India's pharma export sales to grow faster this year, trade body says | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.96% | 12.95B | |
+16.80% | 43.26B | |
+17.47% | 21.6B | |
+21.21% | 15.93B | |
+23.95% | 15.1B | |
-0.05% | 6.79B | |
-16.22% | 6.29B | |
+19.77% | 6.04B | |
-8.87% | 5.73B | |
+27.27% | 4.64B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Gets US FDA's Tentative Approval for Generic Hypertension Drug